Merck 2Q FY26 net loss widens to $1.34 billion; sales rise 5% to $16.61 billion - MRK News | RalliesMerck 2Q FY26 net loss widens to $1.34 billion; sales rise 5% to $16.61 billion
M
MRK• Merck reports wider quarterly loss as sales rise
- Merck posted a GAAP net loss attributable to shareholders of USD 1.34 billion, or USD 0.54 per share, in 2Q26.
- Net sales rose 5% to USD 16.61 billion from a year earlier, while GAAP other income swung to USD 99 million from an expense.
- GAAP loss before taxes widened to USD 683 million from profit, as cost of sales climbed 24% to USD 4.4 billion.
- On a non-GAAP basis, net loss narrowed to USD 330 million, or USD 0.13 per share, from GAAP results.
